Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 10/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.38 |
| ▸ | FPR2 | P25090 | 1/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | CPA1 | P15085 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15156774 | 1.00 | MME (0.45) | MMEOPRM1OPRD1FPR2ADAMTS4 | |
| SCHEMBL3488160 | 1.00 | MME (0.45) | MMEOPRM1OPRD1FPR2ADAMTS4 | |
| SCHEMBL15156784 | 1.00 | MME (0.45) | MMEOPRM1OPRD1FPR2ADAMTS4 | |
| SCHEMBL4075374 | 0.90 | MME (0.53) | MMEGAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL3486795 | 0.90 | MME (0.53) | MMEGAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL3486805 | 0.90 | MME (0.53) | MMEGAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL3486738 | 0.83 | MME (0.47) | MMEHPGDALDH1A1ACECPA1 | |
| SCHEMBL3486210 | 0.81 | MME (0.49) | MMEGAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL15387515 | 0.75 | MME (0.55) | MMEHPGDALDH1A1POLB | |
| SCHEMBL9633609 | 0.75 | MME (0.55) | MMEHPGDALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2809777-B1 | MBTH-LIKE PROTEINS IN THE PRODUCTION OF SEMI SYNTHETIC ANTIBIOTICS | CENTRIENT PHARMACEUTICALS NETHERLANDS B V (NL) | 2019-05-29 | — | — | EP | disclosed |
| EP-2809777-A1 | MBTH-LIKE PROTEINS IN THE PRODUCTION OF SEMI SYNTHETIC ANTIBIOTICS | DSM Sinochem Pharmaceuticals Netherlands B.V. (NL) | 2014-12-10 | — | — | EP | disclosed |
| EP-2084270-B1 | PRODUCTION OF BETA-LACTAM ANTIBIOTICS | DSM SINOCHEM PHARM NL BV (NL) | 2013-11-20 | — | — | EP | disclosed |
| WO-2013113646-A1 | MBTH-LIKE PROTEINS IN THE PRODUCTION OF SEMI SYNTHETIC ANTIBIOTICS | DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) | 2013-08-08 | — | — | WO | disclosed |
| US-8293511-B2 | Production of β-Lactam antibiotics | DSM IP ASSETS B.V. (NL) | 2012-10-23 | — | — | US | disclosed |
| US-20100009404-A1 | PRODUCTION OF BETA-LACTAM ANTIBIOTICS | DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) | 2010-01-14 | — | — | US | disclosed |
| EP-2084270-A2 | PRODUCTION OF BETA-LACTAM ANTIBIOTICS | DSMIP Assets B.V. (NL) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008040731-A2 | PRODUCTION OF BETA-LACTAM ANTIBIOTICS | DSM IP ASSETS B.V. (NL) | 2008-04-10 | — | — | WO | disclosed |